Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Villani

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Dermatology and Therapy|May 23, 2026
Criteria for Hidradenitis Suppurativa Competence CentersAngelo V Marzano, Falk G Bechara, Vivian Y Shi, et al.
Lancet (London, England)|February 6, 2023
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trialsAlexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, et al.
Annales De Dermatologie Et De Venereologie|July 16, 2024
Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithmF Poizeau, S Leducq, L Fardet, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Dermatology and Therapy|May 23, 2026
Criteria for Hidradenitis Suppurativa Competence CentersAngelo V Marzano, Falk G Bechara, Vivian Y Shi, et al.
Lancet (London, England)|February 6, 2023
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trialsAlexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, et al.
Annales De Dermatologie Et De Venereologie|July 16, 2024
Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithmF Poizeau, S Leducq, L Fardet, et al.
Pageof 11